期刊文献+

早期帕金森病患者的临床与^(18)F-FDG PET影像学特征研究 被引量:8

下载PDF
导出
摘要 目的探讨早期帕金森病患者临床特征与18F-FDG正电子发射计算机断层显像的影像学特征及其在帕金森病早期诊断中的价值。方法选择我院神经内科门诊和住院收治的Hoehn-Yahr分级Ⅰ~Ⅱ级早期帕金森患者18例,另设正常对照组,与PD组年龄匹配的对照者20例。所有患者静脉注射18F-FDG后进行正电子发射计算机脑断层显像,获得双侧纹状体、丘脑等部位葡萄糖代谢图像,采用目测法对脑各部位的葡萄糖代谢进行判断,应用PET专用软件计算各ROI的18F-FDG放射性核素值,以枕叶为基准,计算脑部各ROI与枕叶的18F-FDG代谢放射性核素值的比值,在此基础上计算脑部各两两比较的18F-FDG代谢比值。结果早期帕金森组:脑各部结构显示清晰,部分患者大脑皮层显示轻度脑萎缩;大脑皮层示踪剂分布相对均匀,左右对称;皮层下各神经核团显示结构完整,清晰对称;18例早期帕金森病患者18F-FDG正电子计算机断层显像有16例可见脑内有不同程度的放射性分布异常,占88.89%,非对称性纹状体放射性减低14例(77.78%),其中5例为双侧减低,患者的双侧纹状体放射性计数进行半定量比较,发现运动障碍肢体对侧(脑病侧)纹状体尾状核/小脑比值为1.12±0.31,另侧(脑健侧)1.38±0.28,病侧与健侧脑相应区域相比下降,差异显著(t=2.64,P<0.05);壳核/小脑比值分别为1.22±0.28和1.46±0.22(t=2.86,P<0.01)。结论PET显像有助于早期发现亚临床期PD患者纹状体功能改变,可提高早期PD诊断的准确性。PD患者18F-FDGPET显像显示尾状核与壳核团的不对称性代谢减低改变,利用局部ROI的半定量分析方法,能反映出纹状体功能,有助于临床上早期诊断帕金森病并更为客观地评估病情和病程。
出处 《中国现代医药杂志》 2010年第2期61-63,共3页 Modern Medicine Journal of China
  • 相关文献

参考文献12

  • 1全国锥体外系疾病讨论会-帕金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经科杂志,1985,18(4):256-257.
  • 2Uversky VN.Neuropathology,biochemistry,and biophysics of al pha-synuclein aggregation. J Neurochem,2007,103(1):17-37.
  • 3Braak H,Ghebremedhin E,Rub U,et al.Stages in the develop ment of Parkinson's disease-related pathology.Cell Tissue Res, 2004,318(1):121-134.
  • 4Whone AL,Watts RL,Stoessl AJ,et al.Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL- PET study. Ann Neurol,2003,54(1):93-101.
  • 5Owen AM,Doyon J,Dagher A,et al.Abnormal basal ganglia out flow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain,1998,121(Pt 5):949-965.
  • 6Antonini A,Kazumata K, Feigin A,et al.Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET. Mov Disord, 1998,13 (2):268-274.
  • 7Schreckenberger M,Hagele S,Siessmeier T,et al.The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluo rinated PET tracer for the differential diagnosis of parkinsonism. Eur J Nucl Med Mol Imaging,2004,31 (8): 1128-1135.
  • 8Eidelberg D, Moeller JR, Ishikawa T, et al. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography. Neurology,1995,45(11):1995-2004.
  • 9Arahata Y, Hirayama M, Ieda T, et al. Parieto-occipital glucose hy pometabolism in Parkinson's disease with autonomic failure.J Neurol Sci,1999,163(2):119-126.
  • 10Otsuka M,Kuwabara Y,Ichiya Y,et al.Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomograpby with 18F-dupa and ^18F-FDG. Ann Nucl Med, 1997,11(3);251-257.

二级参考文献8

  • 1Ravina B, Eidelberg D, Ahlskog JE, et al . The role of radiotracer imaging in Parkinson disease[J].Neurology, 2005,64:208-215.
  • 2Braak H, Tredici KD,Rub U, et al . Staging of brain pathology related to sporadic Parkinson' s disease[J]. Neurobiol Aging, 2003,24:197-211.
  • 3Hughes AJ, Daniel SE, Kilford L, et al . Accuracy of clinical diagnosis of idiopathic Parkinson's disease:a clinico-pathological study of 100 cases[J]. J Neurol Neurosurg Psychiatry, 1992, 55:181-184.
  • 4Berding G,Odin P,Brooks DJ, et al . Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET[J]. Mov Disord, 2001,16 : 1014-1022.
  • 5Juh R,Pae CU,Lee CU, et al . Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping[J]. Neurosci Res, 2005,52 : 211-219.
  • 6Klein RC, de Jong BM, de Vries JJ, et al . Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease[J]. Mov disord, 2005,20: 1021-1030.
  • 7Hilker R, Voges J, Thiel A, et al . Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDGPET[J].J Neural Transm,2002,109: 1257-1264.
  • 8Nakagawa M, Kuwabara Y, Taniwaki T, et al . PET evaluation of the relationship between D2 receptor binding and glucose metabolism in patients with parkinsonism[J]. Ann Nucl Med, 2005,19:267-275.

共引文献4

同被引文献98

  • 1侯中煜,洪淑惠,姚树展,刘庆伟,林祥涛,宁国庆,孙博,汤煜春,刘树伟.帕金森病猫额、顶叶皮质功能改变的^(18)F-FDG PET/CT研究[J].山东大学学报(医学版),2009,47(8):62-66. 被引量:2
  • 2王大力,张爱国,赵晓晶,苏民,王坚,蒋雨平.磁共振波谱分析对帕金森病临床应用价值的初步研究[J].中国综合临床,2005,21(1):32-33. 被引量:4
  • 3高波,刘树伟.帕金森病的功能影像学研究进展[J].中华老年医学杂志,2005,24(5):389-392. 被引量:2
  • 4周培清.核医学显像技术在帕金森病中的应用[J].内蒙古民族大学学报(自然科学版),2005,20(3):333-335. 被引量:1
  • 5闫卫红,程焱,高硕,蔡莉,李彦生,李大成,邢喜玲.轻型帕金森病D_2受体的PET显像[J].中华神经科杂志,2006,39(6):374-378. 被引量:5
  • 6Thomas J, Wang J, Takuba H, et al. A 6-OHDA induced selective Parkinsonian rat model: further biochemical and behavioural characterization. Exp Neurol, 1994,126 : 159 - 167.
  • 7Martres MP, Bouthenet ML, Sales N, et al. Widespread distribution of brain dopamine receptors evidenced with 1251-sulpride, a highly selective ligand. Science, 1985,228:752-755.
  • 8Guo Y, Gao F, Wang S, et al. In vivo mapping of temporospatial changes in glucose utilization in rat brain during epileptogenesis: An ^18 F-fluorodeoxyglucose-small animal positron emission tomography study. Neuroscience ,2009,162:972-979.
  • 9Zhang H, Zheng XS, Yang XF, et al. ^11 C-NMSp/^18 F-FDG microPET to monitor neural stem cell transplantation in a rat model of traumatic brain injury. Eur J Nucl Med Mol Imaging,2008,35 : 1699-1708.
  • 10Lou M, Zhang H, Wang J, et al. Hyperbaric oxygen treatment attenuated the disease in regional glucose metabolism of rats subieeted to focal cerebral ischemia.. A high resolution postitron emission tomography study. Neuroscience ,2007,146:555-561.

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部